Carisma Therapeutics | 10-K/A: Annual report (Amendment)
Carisma Therapeutics | SCHEDULE 13G/A: Others
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Carisma Therapeutics | 10-K: FY2024 Annual Report
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Klichinsky Michael
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kelly Steven
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer McAndrew Natalie
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 10-Q: Q3 2024 Earnings Report
Carisma Therapeutics | 8-K: Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Carisma Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Cheng Sohanya Roshan
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cheng Sohanya Roshan
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 10-Q: Q2 2024 Earnings Report
Carisma Therapeutics | 8-K: Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights